Internal Medicine, Infectious Disease · Hialeah, FL
NPI
1972686327
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
777 E 25th St Ste 516
Hialeah, FL, 33013
Phone (305) 671-3722
Groups this clinician bills Medicare through
Medicare paid, 2024
$127K
1,557 services
Medicare patients, 2024
516
Average age 74
Drug cost, 2024
$1.5M
637 prescriptions
Company payments, 2025
$1,628
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Andres Rivero was code 99232 (hospital e&m - subsequent), 937 times for 323 patients. In total Andres Rivero billed 1,557 services in 8 codes, and Medicare paid $127K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-11-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 937 | 323 | $64.18 | $60K |
| 99233 Hospital E&M - Subsequent | Facility | 264 | 185 | $97.50 | $26K |
| 99222 Hospital E&M - Initial | Facility | 263 | 248 | $107.96 | $28K |
| 99223 Hospital E&M - Initial | Facility | 76 | 75 | $143.45 | $11K |
| 99214 Office E&M - Established | Office | 14 | 11 | $91.65 | $1,283 |
By year: 2022 $113K for 1,542 services; 2023 $130K for 1,687 services; 2024 $127K for 1,557 services.
Medicare prescription drug claims, 2024
In 2024, the drug Andres Rivero prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 124 prescriptions and refills. In total Andres Rivero wrote 637 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 124 | 124 | 18 | $488K |
| Juluca Dolutegravir/Rilpivirine | 73 | 73 | Under 11 | $254K |
| Dovato Dolutegravir Sodium/Lamivudine | 69 | 69 | Under 11 | $210K |
| Tivicay Dolutegravir Sodium | 52 | 52 | Under 11 | $114K |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 50 | 50 | Under 11 | $232K |
| Prezcobix Darunavir/Cobicistat | 27 | 27 | Under 11 | $64K |
| Efavirenz-Emtric-Tenofov Disop Efavirenz/Emtricit/Tenofovr Df | 22 | 22 | Under 11 | $1,813 |
| Amikacin Sulfate Generic | 19 | 19 | Under 11 | $4,244 |
| Tigecycline Generic | 16 | 16 | Under 11 | $27K |
| Descovy Emtricitabine/Tenofov Alafenam | 14 | 14 | Under 11 | $31K |
| Valacyclovir Valacyclovir Hcl | 14 | 16 | Under 11 | $512 |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 13 | 13 | Under 11 | $53K |
| Ceftriaxone Ceftriaxone Sodium | 12 | 12 | Under 11 | $2,121 |
| Ertapenem Ertapenem Sodium | 12 | 12 | Under 11 | $11K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 11 | 11 | Under 11 | $132 |
Brand drugs: 457 claims; generic drugs: 180 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Andres Rivero $1,628 ($1,628 in general payments such as food, travel and fees) from 9 companies. The largest payer was Gilead Sciences, Inc. with $653.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 12 | $653 |
| ViiV Healthcare Company GSK | 14 | $417 |
| Shionogi Inc 4507.T | 4 | $202 |
| Merck Sharp & Dohme LLC MRK | 4 | $121 |
| Insmed, Inc. INSM | 3 | $82.68 |
| Paratek Pharmaceuticals, Inc. | 3 | $72.35 |
| Theratechnologies Inc. THTX | 1 | $32.29 |
| Melinta Therapeutics, LLC | 1 | $28.63 |
| Cumberland Pharmaceuticals, Inc. CPIX | 1 | $19.41 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.